Apogee Therapeutics, Inc. APGE Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on assets | -27.4%+2.9pp | -30.3%+5.9pp | -36.2%-3.6pp | -32.6%-5.9pp | -26.7%+4.8pp | |
| Liquidity | ||||||
| Current ratio | 32.6×+6.0× | 26.6×+10.7× | 15.9×-0.5× | 16.4×+0.5× | 15.8×-2.7× | |
| Quick ratio | 32.6×+6.0× | 26.6×+10.7× | 15.9×-0.5× | 16.4×+0.5× | 15.8×-2.7× | |
| Cash ratio | 13.7×+9.0× | 4.7×+1.5× | 3.2×-0.8× | 3.9×+0.7× | 3.2×-1.7× | |
| Leverage | ||||||
| Debt-to-assets | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Valuation | ||||||
| Market capitalization | $6.28B+21.8% | $5.16B+118% | $2.37B-6.8% | $2.54B+17.0% | $2.17B-15.8% | |
| Enterprise value | $5.84B+15.9% | $5.03B+122% | $2.27B-6.4% | $2.43B+16.9% | $2.08B-15.2% | |
| Earnings yield | -4.4%+0.6pp | -5%+5.8pp | -10.7%-1.4pp | -9.4%+0.1pp | -9.5%-2.4pp |
Questions, answered.
- Where do Apogee Therapeutics, Inc.'s ratios come from?
- Every ratio is computed from Apogee Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.